Cancer treatments, such as radiotherapy, chemotherapy, and targeted treatments, can have significant effects on the skin. The most common include:
– Dryness and dehydration of the skin.
– Erythema and inflammation (radiation dermatitis).
– Photosensitivity and hyperpigmentation.
– Changes in the nails and skin barrier.
These effects may be temporary or, in some cases, persistent. It is important to adopt a targeted care routine to protect and repair the skin.

Radiation dermatitis is a common side effect that occurs in 95% of patients undergoing radiotherapy. It manifests as redness, itching, and, in the most severe cases, ulcerations. These effects may compromise the continuation of therapy and the patient’s quality of life.

Currently, there are no official guidelines for the treatment of radiation dermatitis, but it is recommended to use specific products that:
Do not contain oily components that may amplify the effects of radiation.
Stimulate skin repair, with active ingredients such as phosphatidylcholine and allantoin
Are easy to apply and compatible with cancer treatments.
Products such as Jalosome® Soothing Gel and Jalosome®Hydrating cream have been formulated to meet these needs.

Oral mucositis is a painful condition that develops in the mucous membranes of the mouth as a result of cancer treatments. The most common symptoms include:
– Burning and intense pain.
– Dry mouth and difficulty swallowing.
– Ulcers and irritation in the oral cavity.
This condition can compromise the patient’s nutrition and quality of life, requiring careful management.

To alleviate the symptoms of mucositis, it is useful to:
– Maintain proper oral hygiene with gentle, alcohol-free products.
– Use barrier gels that protect the mucous membrane from irritation and infection.
– Avoid foods that are too hot, spicy, or acidic.
Jalosome® Oral Barrier is a product formulated to create a protective barrier over the mucous membranes, promoting pain relief and reducing the risk of damage.

Proper management of dermatitis and mucositis enables you to:
– Continue cancer treatment without interruption.
– Reduce pain and improve the patient’s quality of life.
– Prevent long-term complications, such as infections and chronic scarring

Elixi International SA is the official distributor of Jalosome in Switzerland. For more information about the products and their availability, you can contact us by email at info@elixi-int.com